Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Non-Current Assets (2016 - 2017)

Tenax Therapeutics' Non-Current Assets history spans 5 years, with the latest figure at $2.3 million for Q3 2017.

  • For Q3 2017, Non-Current Assets fell 95.5% year-over-year to $2.3 million; the TTM value through Sep 2017 reached $22.9 million, down 85.7%, while the annual FY2016 figure was $9.7 million, N/A changed from the prior year.
  • Non-Current Assets for Q3 2017 was $2.3 million at Tenax Therapeutics, down from $4.5 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $54.0 million in Q2 2016 and bottomed at $2.3 million in Q3 2017.
  • The 3-year median for Non-Current Assets is $9.7 million (2016), against an average of $25.9 million.
  • The largest annual shift saw Non-Current Assets crashed 81.48% in 2016 before it plummeted 95.5% in 2017.
  • A 3-year view of Non-Current Assets shows it stood at $52.4 million in 2015, then plummeted by 81.48% to $9.7 million in 2016, then plummeted by 75.91% to $2.3 million in 2017.
  • Per Business Quant, the three most recent readings for TENX's Non-Current Assets are $2.3 million (Q3 2017), $4.5 million (Q2 2017), and $6.4 million (Q1 2017).